These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35884678)

  • 1. Structural Protein Effects Underpinning Cognitive Developmental Delay of the
    López-Rivera JJ; Rodríguez-Salazar L; Soto-Ospina A; Estrada-Serrato C; Serrano D; Chaparro-Solano HM; Londoño O; Rueda PA; Ardila G; Villegas-Lanau A; Godoy-Corredor M; Cuartas M; Vélez JI; Vidal OM; Isaza-Ruget MA; Arcos-Burgos M
    Brain Sci; 2022 Jun; 12(7):. PubMed ID: 35884678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new case with the recurrent PURA p.(Phe233del) pathogenic variant: Expansion of the phenotype and review of the literature.
    Ben Issa A; Ben Ayed I; Jallouli O; Souissi A; Bouchaalla W; Ben Said M; Mallouli S; Masmoudi S; Charfi Triki C; Hadj Kacem H; Kammoun F
    Int J Dev Neurosci; 2023 Jun; 83(4):383-395. PubMed ID: 37204304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the PURA syndrome phenotype: A child with the recurrent PURA p.(Phe233del) pathogenic variant showing similarities with cutis laxa.
    Cinquina V; Ciaccio C; Venturini M; Masson R; Ritelli M; Colombi M
    Mol Genet Genomic Med; 2021 Jan; 9(1):e1562. PubMed ID: 33275834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Expanding the phenotypic spectrum of PURA syndrome in South America with the first presentation of concurrent vitiligo.
    Mora-Martinez S; Castaño-Giraldo N; Nati-Castillo HA; Barahona Machado L; Mora Arbeláez T; Gordillo-Gonzalez G; Izquierdo-Condoy JS
    Front Pediatr; 2024; 12():1323014. PubMed ID: 38606370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability.
    Hunt D; Leventer RJ; Simons C; Taft R; Swoboda KJ; Gawne-Cain M; ; Magee AC; Turnpenny PD; Baralle D
    J Med Genet; 2014 Dec; 51(12):806-13. PubMed ID: 25342064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the phenotype of PURA-related neurodevelopmental disorder: a close differential diagnosis of infantile hypotonia with psychomotor retardation and characteristic facies.
    Mishra S; Girisha KM; Shukla A
    Clin Dysmorphol; 2021 Jan; 30(1):1-5. PubMed ID: 33229923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the PURA syndrome phenotype with manifestations in a Japanese female patient.
    Fukuda Y; Kudo Y; Saito M; Kaname T; Oota T; Shoji R
    Hum Genome Var; 2022 Apr; 9(1):11. PubMed ID: 35440576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo mutations in PURA are associated with hypotonia and developmental delay.
    Tanaka AJ; Bai R; Cho MT; Anyane-Yeboa K; Ahimaz P; Wilson AL; Kendall F; Hay B; Moss T; Nardini M; Bauer M; Retterer K; Juusola J; Chung WK
    Cold Spring Harb Mol Case Stud; 2015 Oct; 1(1):a000356. PubMed ID: 27148565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of a patient with 5q31.3 microdeletion syndrome and the smallest de novo 5q31.2q31.3 deletion involving PURA.
    Bonaglia MC; Zanotta N; Giorda R; D'Angelo G; Zucca C
    Mol Cytogenet; 2015; 8():89. PubMed ID: 26582469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PURA syndrome: clinical delineation and genotype-phenotype study in 32 individuals with review of published literature.
    Reijnders MRF; Janowski R; Alvi M; Self JE; van Essen TJ; Vreeburg M; Rouhl RPW; Stevens SJC; Stegmann APA; Schieving J; Pfundt R; van Dijk K; Smeets E; Stumpel CTRM; Bok LA; Cobben JM; Engelen M; Mansour S; Whiteford M; Chandler KE; Douzgou S; Cooper NS; Tan EC; Foo R; Lai AHM; Rankin J; Green A; Lönnqvist T; Isohanni P; Williams S; Ruhoy I; Carvalho KS; Dowling JJ; Lev DL; Sterbova K; Lassuthova P; Neupauerová J; Waugh JL; Keros S; Clayton-Smith J; Smithson SF; Brunner HG; van Hoeckel C; Anderson M; Clowes VE; Siu VM; Ddd Study T; Selber P; Leventer RJ; Nellaker C; Niessing D; Hunt D; Baralle D
    J Med Genet; 2018 Feb; 55(2):104-113. PubMed ID: 29097605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel
    Rodríguez-García ME; Cotrina-Vinagre FJ; Arranz-Canales E; Aragón AM; Hernández-Sánchez L; Rodríguez-Fornés F; Carnicero-Rodríguez P; Morales-Conejo M; Martín-Hernández E; Martínez-Azorín F
    J Genet; 2020; 99():. PubMed ID: 32089526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient with a novel purine-rich element binding protein A mutation.
    Okamoto N; Nakao H; Niihori T; Aoki Y
    Congenit Anom (Kyoto); 2017 Nov; 57(6):201-204. PubMed ID: 28164378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypotonic infant with PURA syndrome-related channelopathy successfully treated with pyridostigmine.
    Wyrebek R; DiBartolomeo M; Brooks S; Geller T; Crenshaw M; Iyadurai S
    Neuromuscul Disord; 2022 Feb; 32(2):166-169. PubMed ID: 35094889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PURA, the gene encoding Pur-alpha, member of an ancient nucleic acid-binding protein family with mammalian neurological functions.
    Daniel DC; Johnson EM
    Gene; 2018 Feb; 643():133-143. PubMed ID: 29221753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PURA syndrome-causing mutations impair PUR-domain integrity and affect P-body association.
    Proske M; Janowski R; Bacher S; Kang HS; Monecke T; Koehler T; Hutten S; Tretter J; Crois A; Molitor L; Varela-Rial A; Fino R; Donati E; De Fabritiis G; Dormann D; Sattler M; Niessing D
    Elife; 2024 Apr; 13():. PubMed ID: 38655849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding the clinical phenotype and genetic spectrum of PURA-related neurodevelopmental disorders.
    Choi SA; Lee HS; Park TJ; Park S; Ko YJ; Kim SY; Lim BC; Kim KJ; Chae JH
    Brain Dev; 2021 Oct; 43(9):912-918. PubMed ID: 34116881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of
    Boczek NJ; Macke EL; Kemppainen J; Klee EW; Renaud DL; Gavrilova RH
    Child Neurol Open; 2020; 7():2329048X20955003. PubMed ID: 33117858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PURA syndrome: neuromuscular junction manifestations with potential therapeutic implications.
    Qashqari H; McNiven V; Gonorazky H; Mendoza-Londono R; Hassan A; Kulkarni T; Amburgey K; Dowling JJ
    Neuromuscul Disord; 2022 Oct; 32(10):842-844. PubMed ID: 36210261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal PURA syndrome: a case report and literature review.
    Liu Y; Liu R; Xu T; Zhou YX; Zhang SC
    Transl Pediatr; 2021 Jan; 10(1):194-203. PubMed ID: 33633953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in PURA cause profound neonatal hypotonia, seizures, and encephalopathy in 5q31.3 microdeletion syndrome.
    Lalani SR; Zhang J; Schaaf CP; Brown CW; Magoulas P; Tsai AC; El-Gharbawy A; Wierenga KJ; Bartholomew D; Fong CT; Barbaro-Dieber T; Kukolich MK; Burrage LC; Austin E; Keller K; Pastore M; Fernandez F; Lotze T; Wilfong A; Purcarin G; Zhu W; Craigen WJ; McGuire M; Jain M; Cooney E; Azamian M; Bainbridge MN; Muzny DM; Boerwinkle E; Person RE; Niu Z; Eng CM; Lupski JR; Gibbs RA; Beaudet AL; Yang Y; Wang MC; Xia F
    Am J Hum Genet; 2014 Nov; 95(5):579-83. PubMed ID: 25439098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.